New Homogeneity & Stability Testing Module released
QuoData is excited to announce a powerful new addition to its clinical EQA software-as-a-service suite Cequator – a powerful Homogeneity & Stability Testing module. This feature allows EQA providers to analyze homogeneity and stability data of EQA/PT samples as required by ISO 17043.
Homogeneity and stability are critical factors in ensuring accurate and reproducible results when using EQA/PT samples. The new module followst he protocols of ISO 13528 and streamlines the analysis process with:
First Web-Seminar: Implementing ISO 17043:2023 - Guidelines for Laboratory PT Sample Production and Distribution
On June 5, 2024, QuoData successfully hosted a web-seminar on "Implementing ISO 17043:2023 - Guidelines for Laboratory PT Sample Production and Distribution." Martin Jähne, QuoData's Head of Laboratory, guided participants through the critical updates and changes in the ISO 17043:2023 standard.
The ISO 17043 standard, updated in 2023, includes several significant changes:
Incorporation of inspection and sampling as further conformity assessment activities in the standard
Q/Hampel Web service for PT providers
Please be aware that evaluation can take up to 4 hours1.
You will receive an email notification once the results are ready.
1The following business hours apply: Monday to Friday from 9:00 a.m. to 5:00 p.m. (UTC +2).
Formation of Cysteine Adducts with Chlorogenic Acid in Coffee Beans
Formation of Cysteine Adducts with Chlorogenic Acid in Coffee Beans
Tchewonpi, Sorel Sagu; Ulbrich, Nina; Morche, Johanna Rebekka; Nichani, Kapil, Özpinar, Haydar; Schwarz, Steffen; Henze, Andrea; Rohn, Sascha; Rawel, Harshadrai M. (2024)
Published in:
MetaInvert-ISO: QuoData Teams Up with Leading Institutions to Safeguard Soil Biodiversity
Exploring Artificial Intelligence for Life Science SMEs: Successful Event Hosted by QuoData with biosaxony
The "biosaxony vor Ort – AI for SMEs" event held on March 14, 2024, at the QuoData headquarters, was a resounding success. Filled with vibrant energy from enthusiastic participants and insights shared by esteemed speakers, it was an enriching experience.
The event kicked off with a brief opening by Conny Lerche, followed by Anja Rösler's introduction to biosaxony and its current initiatives. Continuing the program, QuoData’s Senior Data Scientist, Kapil Nichani, delved into "Embracing AI: Transforming measurement data into insights and actions".
Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy
Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy
Geiger, Kimberly; Joerger, Markus; Roessler, Max; Hettwer, Karina; Ritter Christoph; Simon, Kirsten; Uhlig, Steffen; Holdenrieder, Stefan (2024)
Exploring AI in Life Sciences: QuoData hosts "biosaxony vor Ort"
Exploring AI in Life Sciences: QuoData hosts "biosaxony vor Ort"
QuoData is honored and excited to take the lead in hosting the upcoming "biosaxony vor Ort" event on March 14, 2024, from 4 pm to 6:25 pm at our headquarters on Prellerstrasse 14.
Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy – A CEPAC-TDM biomarker substudy
Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy – A CEPAC-TDM biomarker substudy
Geiger, Kimberly; Joerger, Markus; Roessler, Max; Hettwer, Karina; Ritter Christoph; Simon, Kirsten; Uhlig, Steffen; Holdenrieder, Stefan (2024)
Published in:
Tumor Biology: https://content.iospress.com/articles/tumor-biology/tub230015
The Emergence of Maia - An open-source tool for video analysis of iPSC-CMs
The Emergence of Maia - An open-source tool for video analysis of iPSC-CMs
There's a tremendous growth noticed in the studies of induced pluripotent stem-cells derived cardiomyocytes (iPSC-CMs). Biomedical image & signal processing techniques are increasingly used in the analysis of stem cell studies, regenerative & therapeutic medicines, organ-on-chip studies, etc.